@article{270b26c41fbd4d9aabf9426a750984d4,
title = "Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations",
keywords = "Cardiovascular disease, Cholesterol management, Dyslipidemia, NHANES, Statin",
author = "Sidiq, \{Sameer A.\} and Zhang, \{Geoffrey Y.\} and Dmitry Abramov and Razavi, \{Alexander C.\} and Vijay Nambi and Xiaoming Jia and Virani, \{Salim S.\} and Ballantyne, \{Christie M.\} and Blumenthal, \{Roger S.\} and Minhas, \{Abdul Mannan Khan\}",
note = "Publisher Copyright: {\textcopyright} 2026 National Lipid Association.",
year = "2026",
doi = "10.1016/j.jacl.2026.07.008",
language = "English",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
}